-
2026.09.04
VOLUNTARY ANNOUNCEMENT The Approval of LuX-Valve Plus by the Hong Kong Department of Health
-
2026.09.04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2026
-
2026.08.31
INTERIM RESULTS ANNOUNCEMENT
FOR THE SIX MONTHS ENDED 30 JUNE 2026
-
2026.08.31
REVISION OF ANNUAL CAPS UNDER THE MEDICAL DEVICES
ACCESSORIES PURCHASE AGREEMENT
-
2026.08.19
NOTICE OF BOARD MEETING
-
2026.08.10
INSIDE INFORMATION
FORECAST OF 2026 INTERIM REVENUE
-
2026.08.06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2026
-
2026.07.16
VOLUNTARY ANNOUNCEMENT THE SUCCESSFUL COMPLETION OF FIRST BATCH OF IMPLANTATION IN THE FDA IDE PIVOTAL TRIAL FOR LUX-VALVE PLUS
-
2026.07.08
VOLUNTARY ANNOUNCEMENT LuX-Valve Plus Obtained the EU MDR CE Certification
-
2026.07.07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026